Page 6 - சிங்கப்பூர் பரிமாற்றம் பத்திரங்கள் வர்த்தக வரையறுக்கப்பட்டவை News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Investegate |Global Invacom Group Announcements | Global Invacom Group: Death of UK Financial Controller
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
Lime Petroleum Norway : US$60 million senior secured bond issue completed
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
UP Fintech Holding Limited (TIGR) Profit Margins posted 17 30% in the last twelve months: The key fundamentals to watch
investchronicle.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investchronicle.com Daily Mail and Mail on Sunday newspapers.
EQS-News: Lonza Group AG: Lonza Completes Divestment of Specialty Ingredients Business
Lonza Completes Divestment of Specialty Ingredients Business
02.07.2021 / 07:00
Basel, Switzerland, 2 July 2021 -
Lonza announced today the completion of the divestment of its former Specialty Ingredients business and operations to Bain Capital and Cinven for an enterprise value of CHF 4.2 billion.
Albert M. Baehny, Chairman, Lonza commented: Since announcing our intention to divest the Specialty Ingredients business, we have made significant progress in consolidating our new structure and identity and refining our focus as a pure-play partner to the healthcare industry. As the divestment of the Specialty Ingredients business completes, at Lonza we have an opportunity to consolidate our identity and redouble our focus on long-term growth while delivering value for our customers, employees and shareholders.
EQS-News: Lonza Completes Divestment of Specialty Ingredients Business
vom 02.07.2021, 07:00 Uhr
Bild: pixabay.com
Lonza Completes Divestment of Specialty Ingredients Business
02.07.2021 / 07:00
Basel, Switzerland, 2 July 2021 -
Lonza announced today the completion of the divestment of its former Specialty Ingredients business and operations to Bain Capital and Cinven for an enterprise value of CHF 4.2 billion.
Albert M. Baehny, Chairman, Lonza commented: Since announcing our intention to divest the Specialty Ingredients business, we have made significant progress in consolidating our new structure and identity and refining our focus as a pure-play partner to the healthcare industry. As the divestment of the Specialty Ingredients business completes, at Lonza we have an opportunity to consolidate our identity and redouble our focus on long-term growth while delivering value for our customers, employees and shareholders.